SBC
SBC Medical Group Holdings Inc
$2.87
-4.01%
$295.2M
No data for this timeframe.
Vol
Market Cap$295.2M
Cap SizeMicro Cap
Inst. Holders23 funds
Inst. Value$3.5M
Inst. Activity0 buys / 3 sells
Insider Activity0B / 3S
Insider Net $-$20.2M
Reddit Sentiment28° Bearish
SEC Reports1
Press Releases1
Exchange Nasdaq·Sector Services-Offices & Clinics of Doctors of Medicine·Inc. DE·CIK 0001930313·Prev Close $2.99
Recent Activity
May 26, 2026
other
SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC will participate in several upcoming investor conferences in May and June 2026.
May 1, 2026
SEC
SBC Medical announces its Q1 2026 earnings release date for May 14, 2026, and a conference call. No financial results ar
PRESS-RELEASE — Impact 2/10
Apr 28, 2026
Insider
Aikawa Yoshiyuki sold 465,000 shares
Chairman and CEO @ $3.02 ($1.4M)
Apr 21, 2026
Insider
Aikawa Yoshiyuki sold 3,100,000 shares
Chairman and CEO @ $3.02 ($9.4M)
Mar 6, 2026
Insider
Aikawa Yoshiyuki disposed of 44,229 shares
Chairman and CEO
Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — TRIM
18,201 shares ($76.1K)
Inst.
MORGAN STANLEY — TRIM
8,399 shares ($35.1K)
May 22, 2026
Press
SBC Medical Group announced a consulting partnership with BLEZ ASIA to open a new aesthetic dermatology section in Bangk
Impact 2/10
Price Targets
Historical data — last covering-analyst action Mar 2026. No current recommendation available.
$8.50 (Mar 2026)
Current $2.87
Low $7.00
Median $8.50
High $10.00
4 analysts
$7.00
$10.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 6, 2026 | BTIG | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.12 | $0.11 — $0.13 | 488% YoY | 4 |
| Next Q | $0.12 ▼ -2.0% | $0.11 — $0.13 | 0% YoY | 4 |
| Current FY | $0.47 ▲ +1.6% | $0.43 — $0.50 | -7% YoY | 4 |
| Next FY | $0.48 | $0.48 — $0.49 | 4% YoY | 2 |
Latest Reports
NEUTRAL
Press
2/10
SBC Medical Group announced a consulting partnership with BLEZ ASIA to open a new aesthetic dermatology section in Bangk
May 22, 2026
NEUTRAL
PRESS-RELEASE
2/10
SBC Medical announces its Q1 2026 earnings release date for May 14, 2026, and a conference call. No financial results ar
May 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $1.8M | ADD |
| VANGUARD CAPITAL MANAGEMENT LLC | $569.5K | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $265.6K | — |
| VANGUARD FIDUCIARY TRUST CO | $261.1K | — |
| STATE STREET CORP | $128.9K | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 28, 2026 | Aikawa Yoshiyuki | SELL | $1.4M |
| Apr 21, 2026 | Aikawa Yoshiyuki | SELL | $9.4M |
| Mar 6, 2026 | Aikawa Yoshiyuki | J | $0.00 |
| Mar 6, 2026 | Aikawa Yoshiyuki | J | $0.00 |
| Mar 6, 2026 | Aikawa Yoshiyuki | SELL | $9.4M |
Reddit Sentiment
28°▲
Bearish
Bearish
Neutral
Bullish
23 institutional holders with $3.5M total value (848,679 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, VANGUARD. Net selling activity: 3 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 419,640 | $1.8M | 49.4% | ADD +57.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 136,239 | $569.5K | 16.1% | — |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 63,547 | $265.6K | 7.5% | — |
| 4 | VANGUARD FIDUCIARY TRUST CO | 62,473 | $261.1K | 7.4% | — |
| 5 | STATE STREET CORP | 30,839 | $128.9K | 3.6% | ADD +53.7% |
| 6 | GOLDMAN SACHS GROUP INC | 25,087 | $104.9K | 3.0% | — |
| 7 | Mariner, LLC | 23,960 | $100.2K | 2.8% | — |
| 8 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 18,201 | $76.1K | 2.1% | TRIM -33.4% |
| 9 | Russell Investments Group, Ltd. | 13,589 | $56.8K | 1.6% | DOUBLED +292.0% |
| 10 | Nuveen, LLC | 12,368 | $51.7K | 1.5% | — |
| 11 | Vanguard Global Advisers, LLC | 8,557 | $35.8K | 1.0% | — |
| 12 | MORGAN STANLEY | 8,399 | $35.1K | 1.0% | TRIM -45.8% |
| 13 | RHUMBLINE ADVISERS | 6,447 | $26.9K | 0.8% | TRIM -32.8% |
| 14 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 5,357 | $22.4K | 0.6% | DOUBLED +105.1% |
| 15 | WELLS FARGO & COMPANY/MN | 4,250 | $17.8K | 0.5% | DOUBLED +195.1% |
| 16 | FMR LLC | 3,388 | $14.2K | 0.4% | DOUBLED +1044.1% |
| 17 | BARCLAYS PLC | 3,173 | $13.3K | 0.4% | — |
| 18 | ROYAL BANK OF CANADA | 1,307 | $6.0K | 0.2% | — |
| 19 | CWM, LLC | 738 | $3.1K | 0.1% | TRIM -43.2% |
| 20 | CITIGROUP INC | 594 | $2.5K | 0.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | TRIM | 27,341 | 18,201 | -33.4% | $76.1K | 2026-Q1 |
| MORGAN STANLEY | TRIM | 15,506 | 8,399 | -45.8% | $35.1K | 2026-Q1 |
| Allworth Financial LP | TRIM | 3 | 2 | -33.3% | $9.00 | 2026-Q1 |
| BlackRock, Inc. | ADD | 271,776 | 426,567 | +57.0% | $1.8M | 2025-Q4 |
| VANGUARD GROUP INC | DOUBLED | 81,100 | 269,582 | +232.4% | $1.2M | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 14,267 | 27,341 | +91.6% | $117.8K | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 5,894 | 15,506 | +163.1% | $66.8K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 4,278 | 12,626 | +195.1% | $54.4K | 2025-Q4 |
| Russell Investments Group, Ltd. | DOUBLED | 3,004 | 11,775 | +292.0% | $50.8K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 2,592 | 7,883 | +204.1% | $34.0K | 2025-Q4 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | DOUBLED | 2,545 | 5,221 | +105.1% | $22.5K | 2025-Q4 |
| FMR LLC | DOUBLED | 338 | 3,867 | +1044.1% | $16.7K | 2025-Q4 |
| Allworth Financial LP | TRIM | 6 | 3 | -50.0% | $14.00 | 2025-Q4 |
| CWM, LLC | TRIM | 1,149 | 653 | -43.2% | $3.00 | 2025-Q4 |
| VANGUARD GROUP INC | DOUBLED | 35,081 | 81,100 | +131.2% | $352.0K | 2025-Q3 |
| STATE STREET CORP | ADD | 20,200 | 31,039 | +53.7% | $134.7K | 2025-Q3 |
| RHUMBLINE ADVISERS | TRIM | 9,645 | 6,478 | -32.8% | $28.1K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 8,245 | 5,894 | -28.5% | $25.6K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 1,766 | 2,592 | +46.8% | $11.2K | 2025-Q3 |
| FMR LLC | DOUBLED | 22 | 338 | +1436.4% | $1.5K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 61,343 | 2,391 | -96.1% | $11.1K | 2025-Q2 |
| UBS Group AG | DOUBLED | 23,739 | 61,343 | +158.4% | $195.7K | 2025-Q1 |
| UBS Group AG | DOUBLED | 3,210 | 23,739 | +639.5% | $132.0K | 2024-Q4 |
1 unique insiders with 5 transactions. Net insider value: -$20.2M ($0.00 bought, $20.2M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | Aikawa Yoshiyuki | Chairman and CEO | SELL | 465,000 | $3.02 | $1.4M |
| Apr 21, 2026 | Aikawa Yoshiyuki | Chairman and CEO | SELL | 3,100,000 | $3.02 | $9.4M |
| Mar 6, 2026 | Aikawa Yoshiyuki | Chairman and CEO | J | 44,229 | — | — |
| Mar 6, 2026 | Aikawa Yoshiyuki | Chairman and CEO | J | 44,229 | — | — |
| Mar 6, 2026 | Aikawa Yoshiyuki | Chairman and CEO | SELL | 4,422,900 | $2.12 | $9.4M |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 2.0/10.
Historical analyst distribution (last covering-analyst action Mar 2026): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Mar 2026. No current recommendation available.
$8.50 mean target (Mar 2026)
$7.00 Low
$10.00 High
| Metric | Value |
|---|---|
| Current Price | $2.87 |
| Target Low | $7.00 |
| Target Mean | $8.50 |
| Target Median | $8.50 |
| Target High | $10.00 |
| # Analysts | 4 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.12 | $0.11 | $0.13 | 487.5% | +0.0% | 1↑ 1↓ | $0.0B | 4.8% | 4 |
| Next Q 2026-09-30 |
$0.12 | $0.11 | $0.13 | 0.0% | -2.0% | — | $0.0B | 6.0% | 4 |
| Current FY 2026-12-31 |
$0.47 | $0.43 | $0.50 | -7.0% | +1.6% | 2↑ 1↓ | $0.2B | 4.3% | 4 |
| Next FY 2027-12-31 |
$0.48 | $0.48 | $0.49 | 4.3% | — | — | $0.2B | 8.5% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.117 | |
| 7d ago | $0.117 | |
| 30d ago | $0.117 | |
| 60d ago | $0.123 | -0.006 |
| 90d ago | $0.123 | -0.006 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 6, 2026 | BTIG | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% | |
| Feb 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% | |
| Jan 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
28°
Bearish
Bearish
Neutral
Bullish
12 mentions
1 bullish
8 bearish
12 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 11, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Jun 11, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Jun 10, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Jun 10, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Jun 9, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Jun 9, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 30, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 30, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 17, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 17, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Feb 25, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Feb 16, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
May 26, 2026
other
SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC will participate in several upcoming investor conferences in May and June 2026.
May 22, 2026
contract
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
Japanese-Quality Pico Laser Treatment to Serve the Growing Thai Aesthetic Healthcare Market, with Service Launch Scheduled for June 2026 <pre>Japanese
May 14, 2026
earnings_calendar
SBC Q1 2026 Earnings Scheduled — 2026-05-14
May 1, 2026
earnings
SBC Medical to Announce 1Q 2026 Financial Results
SBC Medical Group Holdings Inc will announce first quarter 2026 financial results on May 14, 2026.
Mar 27, 2026
earnings_calendar
SBC Q4 2025 Earnings Scheduled — 2026-03-27